TABLE 3

Relationship between the number of mast cells and the number of inflammatory cells in bronchoalveolar lavage, in the submucosa, and with markers of remodelling in children with asthma

AsthmaCorrelations
SM c-kit mm−2ASM c-kit mm−2Giemsa mm­−2
Number of patients36
Bronchoalveolar lavage ×103·mL−1
 Macrophages62.2 (35.5–83.4)p=0.07, r= −0.38p=0.45, r= −0.16p=0.09, r= −0.34
 Eosinophils1 (0.7–3.5)p=0.11, r=0.20p=0.46, r=0.13p=0.17, r=0.25
 Neutrophils3.6 (2.3–6.5)p=0.45, r=0.14p=0.38, r=0.16p=0.97, r= −0.01
 Mast cells0 (0–0)p=0.65, r=0.09p=0.22, r=0.25p=0.09, r=0.34
 Lymphocytes4 (3.3–6.5)p=0.21, r=0.23p=0.63, r=0.09p=0.17, r=0.24
Submucosal infiltration mm−2
 Eosinophils8.5 (5.1–20.3)p<0.01, r=0.44p=0.02, r=0.40p<0.01, r=0.44
 Neutrophils44.1 (30.5–59.3)p=0.10, r= −0.28p=0.28, r= −0.19p=0.23, r= −0.21
 Lymphocytes131.4 (93.1–190.7)p=0.36, r=0.19p=0.30, r=0.22p=0.20, r=0.26
Markers of remodelling
 RBM thickness µm6.8 (5.5–8.4)p=0.22, r=0.21p=0.13, r=0.26p=0.11, r=0.27
 ASM area %16.5 (10–23.8)p=0.45, r=0.14p=0.99, r<0.01p=0.90, r= −0.02
 Vessel number per 0.1 mm220 (13–30)p=0.33, r= −0.17p=0.90, r=0.02p=0.74, r=0.06
 Mucus gland area %8 (3–20.3)p=0.94, r= −0.01p=0.77, r= −0.06p=0.16, r= −0.26
 Epithelial integrity %55 (30–80)p=0.22, r= −0.22p=0.56, r= −0.11p=0.61, r= −0.09
  • Data are presented as median (interquartile range), unless otherwise stated. SM: submucosal; ASM: airway smooth muscle; RBM: reticular basement membrane.